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Abstract 
Subjective memory complaints (SMC) are a criterion in many definitions of mild cognitive 
impairment (MCI). However, there is controversy over whether this is useful and appropriate, 
as previous research has suggested that SMC may be a function of mood problems such as 
anxiety and depression. This paper aimed to establish the relationship between MCI and 
mood in older people and to investigate the role that SMC play in the relationship. Structured 
interviews were conducted with community dwelling older people in Wales to collect 
information regarding cognitive functioning, mood and well-being. A widely-used algorithm 
was used to categorise 3173 participants into three groups: not cognitively impaired, MCI 
including SMC (MCI), and MCI without SMC (MCIW). The odds of experiencing anxiety or 
depression were calculated for each cognitive group. Participants with MCI had increased 
odds of experiencing symptoms of both anxiety and depression, but the odds were not 
changed for participants in the not cognitively impaired or MCIW categories. A mediation 
analysis was performed on the whole sample using cognition as a dichotomous variable, 
grouped using an age-, education-, and gender-adjusted median cut off point. This showed 
that SMC partially mediated the relationship between anxiety and cognition, and depression 
and cognition. Mood problems may be related to SMC rather than objective cognitive 
impairment, as only participants with MCI that included SMC showed increased odds of 
experiencing anxiety and depression. SMC are likely to play a mediating role in the 
relationship between mood and cognitive functioning.  
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Introduction 
Mild cognitive impairment (MCI) is a categorisation that may be applied to older 
people who experience a level of cognitive decline considered more severe than normal 
ageing but not thought sufficient in extent or severity to constitute dementia [1]. The broader 
MCI definition encompasses the following criteria: an objective impairment in memory or 
other cognitive domains such as language, a subjective memory complaint, absence of 
dementia, intact general cognition and intact activities of daily living [2-5]. Currently, several 
variants of this definition exist, and such variations differ in the extent to which they endorse 
the criteria above [6].  
The role of subjective memory complaints (SMC) in the MCI definition is questioned 
by researchers as some studies have found it to lack accuracy as a diagnostic criterion [7] and 
level of awareness has been found to vary amongst individuals with MCI, with some over-
and others under-estimating extent of difficulties [8]. SMC are common in the healthy older 
population [9] but show little relationship with either informant reports or cognitive test 
results [10]. Previous research has also found that as many as 62% of individuals 
experiencing cognitive decline do not report it [11], suggesting that whilst SMC can be 
experienced by those without impairments, and often may not be experienced by those with 
impairments. Older people in advanced stages of cognitive decline may experience 
anosognosia, and lack awareness of memory problems. This may be for several reasons, such 
as neurological changes within the brain which may disrupt cognitive processes required for 
attention, or perhaps due to social cognitive processes, where an individual may attempt to 
cover up the extent of their memory problems in order to minimise their difficulties [12].  
Investigating SMC is important as evidence has shown a link between SMC and 
future cognitive decline. Schmand et al. [13] found that SMC were associated with greater 
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odds of having a dementia diagnosis after four years. Reisberg at al. [14] reported that 
otherwise healthy community dwellers presenting at outpatients departments with subjective 
cognitive impairment (SCI) were more likely to experience subsequent cognitive decline than 
people without SCI. There is also a growing body of research investigating subjective 
cognitive decline as a distinct stage on the cognitive continuum between normal ageing and 
dementia. Subjective cognitive decline is thought to occur before MCI and potentially 
represents a stage when the person is aware of changes in cognitive functioning, but these 
changes are not detected by formal testing. Jessen et al [15] suggest a model of three 
consecutive stages whereby an individual progresses from subjective memory impairment 
(SMI) to MCI, and on further to dementia, finding that participants presenting with SMI were 
at increased risk of conversion to any form of dementia at follow-up time points of 18 months 
and three years from baseline.   
One plausible explanation for the discrepancy in the relationship between SMC and 
cognitive decline could be the influence of mood, such as symptoms of anxiety or depression. 
Anxiety and depression are related to MCI [16, 17] and also to SMC [18, 19]. This study will 
accordingly address the following questions: 
1. Are people with MCI more likely to have symptoms of anxiety or depression than 
people without cognitive impairment? 
2. Are people with SMC more likely to report symptoms of anxiety and depression 
than those without SMC? 
3. Do SMC mediate the relationship between cognitive impairment and symptoms of 
anxiety or depression? 
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Method 
Design 
Mood, cognitive functioning and SMC were examined using cross-sectional data from 
a large sample of community dwelling older people who participated in the Cognitive 
Functioning and Ageing Study Wales (CFAS Wales). CFAS Wales is a longitudinal 
population-based study which has gathered information about participants drawn from two 
research centres in urban and rural areas of Wales, investigating changes that people may 
experience as they age. Participants took part in face-to-face interviews, which were usually 
conducted in their own homes, with trained interviewers through the medium of English or 
Welsh, depending on the participant’s preference. Ethical approval was granted by the 
appropriate NHS Ethics committee. This paper presents data from the first wave of 
interviews.  
Participants 
Individuals over 65 years and living in the Gwynedd, Ynys Môn and Neath Port 
Talbot areas of Wales were randomly sampled from general practice lists between 2011 and 
2013, with equal numbers drawn from the age groups 65-74 and 75 and above. Participants 
were excluded from the analyses reported here if they had a diagnosis of dementia (n=129), 
impaired activities of daily living (ADLs) (n=52) or cognitive decline greater than that 
expected for a classification of MCI, but not meeting the criteria for dementia for other 
reasons (other cognitive impairment no dementia; OCIND; n=152) resulting in n=3173 
participants included in this analysis. 
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Definition of subjective memory complaints 
Subjective memory complaints were indicated by a self-report of memory problems 
by the participant. This was assessed using the following questions asked during the 
structured interview: “Have you ever had any difficulty with your memory?” and “Have you 
tended to forget things recently?” A positive answer to either question resulted in a 
participant being categorised as having SMC, which was a dichotomous category. 
Assessment of mood 
Symptoms of anxiety and depression were assessed during the structured interview. 
Anxiety and depression were defined using the Geriatric Mental State Automated Geriatric 
Examination for Computer Assisted Taxonomy (GMS-AGECAT) algorithm [20], where a 
score of two indicated mild symptoms and a score of three or above indicated a case-level 
anxiety or depression. For the purposes of this study, scores of 0 and 1 were considered in the 
‘normal’ range. 
Classification of cognitive status 
MCI was defined using the cognitive status algorithm [21] (see Figure 1). Participants 
classified as having MCI displayed an objective cognitive impairment, intact general 
cognitive functioning (indicated by a score greater than or equal to 22 on the MMSE), intact 
ADLs, an absence of dementia and SMC. Objective cognitive impairment was defined using 
the CAMDEX CAMCOG [22] which formed a section of the structured interview. A score 
falling one standard deviation below age-adjusted norms [23] on any cognitive domain 
measured in the CAMCOG represented impairment. 
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A further group of participants was created using the cognitive status algorithm 
(Figure 1) that included all participants who would otherwise meet criteria for MCI, except 
that they did not report SMC. This group was referred to as MCI-without (MCIW). 
Participants in the OCIND, ADL or dementia categories, defined using the cognitive 
status algorithm (Figure 1) were excluded from analyses as they represented a level of 
impairment greater than would be expected for a classification of MCI. 
For use in mediation analyses, a median split on the total CAMCOG score was used 
adjusting for age, gender and education  
Statistical analyses 
Analyses were conducted using SPSS 20.0. Differences between participants with and 
without SMC were described. Logistic regression was conducted to determine the odds of 
experiencing symptoms of anxiety or depression for each cognitive status and for participants 
with and without SMC. Mediation analyses were conducted to investigate the amount of 
variance in the relationship between MCI and mood problems that could be explained by the 
presence of SMC. The mediation analyses were conducted using the median split of the 
CAMCOG, symptoms of anxiety or depression as the outcome variable and the presence of 
SMC as the mediating variable, using logistic regression. Sobel’s test was used to determine 
mediation analyses were significant, and that any reduction in variance attributed to the 
mediating variable was a significant amount. Sensitivity analyses were also conducted and 
can be found in the supplementary material, in order to identify an appropriate index of 
cognition that met the criteria for mediation i.e. was significantly related to both SMC and 
mood. 
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Results 
The characteristics of the study sample are shown in Table 1 and Table 2. Data were 
analysed from 3173 participants who were classified according to cognitive status as having 
no cognitive impairment (NCI), MCI or MCIW. SMC were reported by 1050 participants 
(33.1%), with 200 participants (6.3%) meeting criteria for MCI and 329 participants (10.4%) 
being categorised as MCIW. 
 
(((Table 1 here))) 
 
(((Table 2 here))) 
 
Are people with MCI more likely to have symptoms of anxiety or depression compared to 
people without cognitive impairment? 
Logistic regression showed that the odds of experiencing symptoms of anxiety were 
significantly increased in people who had been classified as having MCI (OR=1.93, CI=1.16-
3.22, p=.012) but not for people classified as MCIW (OR=0.68, CI=0.37-1.23, p=.199) or 
people without cognitive impairment (OR=0.88, CI=0.59-1.32, p=.542). The same pattern 
was found for the odds of experiencing symptoms of depression, where the risks were 
significantly increased in people who had been classified as having MCI (OR=2.04, CI=1.52-
2.74, p<.001) but not for people classified as MCIW (OR=1.01, CI=0.77-1.31, p=.968), and 
the odds were significantly decreased in participants with no cognitive impairment (OR=0.72, 
CI=0.59-0.88, p=.002). 
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Are people with SMC more likely to report symptoms of anxiety and depression than those 
without SMC? 
The odds of experiencing symptoms of anxiety and depression were significantly 
increased in participants who had reported subjective memory complaints (anxiety OR=2.25, 
CI=1.64-3.09, p<.001; depression OR=2.02, CI=1.71-2.39, p<.001), regardless of their 
cognitive status. The number of people reporting SMC for each AGECAT level of anxiety 
and depression are shown in Table 3. Data from participants in the NCI group were also 
analysed separately to determine whether the presence of SMC changed the odds of anxiety 
or depression in people without cognitive impairment. Logistic regression showed that the 
odds of both anxiety (OR=2.17, CI=1.53-3.08, p<.001) and depression (OR=2.02, CI=1.68-
2.43, p<.001) were significantly increased in participants without cognitive impairment who 
reported SMC. 
 
(((Table 3 here))) 
 
Do SMC mediate the relationship between cognition and symptoms of anxiety or depression? 
Logistic regression was used to investigate whether SMC mediate the relationship 
between cognition and anxiety in the whole sample (MCI, MCIW & NCI). Sensitivity 
analyses conducted prior to mediation analyses indicated that using cognition as a 
dichotomous variable created by an age-, education- and gender-adjusted median split of the 
total CAMCOG score would be most appropriate, as this variable had a relationship with 
anxiety (OR=0.65, CI=0.47-0.89, p=.008), whereas cognition  as a continuous variable did 
not (see Supplementary Material, Table S1). Mediation analyses suggested that the 
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association between cognition and anxiety is partially mediated by the presence of SMC 
(Figure 2A), and the results of the Sobel test suggest that the mediation effect was significant, 
z’=-2.30, p=.021. 
 The CAMCOG median split variable was also used as the measure of cognition in 
testing for mediation between cognition and depression in order to maintain continuity, 
although other measures of cognition were assessed in sensitivity analyses (see 
Supplementary Material, Table S2). In this analysis, the total effect of cognition on 
depression was significant (OR=0.70, CI=0.59-0.82, p<.001). Mediation analyses show that 
the association between cognition and depression was partially mediated by the presence of 
SMC (Figure 2B) and the results of the Sobel test suggest that this mediation was also 
significant, z’=-2.48, p=.013.  
 
(((Figure 2 here))) 
 
Discussion 
 This study aimed to investigate the relationship between MCI, mood and SMC, using 
data from a large population study of people over 65 years old living in Wales. The findings 
suggest that the odds of experiencing symptoms of both anxiety and depression were 
significantly increased in people categorised as having MCI (where SMC are part of the 
criteria), but the odds are not changed for people with no cognitive impairment or for those 
otherwise meeting criteria for MCI who do not report SMC. Reports of SMC were also 
associated with increased odds of having symptoms of anxiety and depression across all 
cognitive status groups compared to people who did not report SMC. Mediation analyses 
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suggested that the relationship between cognition and mood may be partly accounted for by 
their mutual relationship with SMC. 
 The findings from the present study echo the results of previous studies that have also 
shown an association between MCI and mood [24-27]. SMC may occur due to an 
individual’s attributional style and may therefore be related to depression as a function of 
negative attributions, rather than due to cognitive impairment [10, 18]. The relationship 
between MCI and anxiety may operate in two directions. On one hand, concerns over 
memory may influence general levels of anxiety, as memory problems can be frightening and 
anxiety provoking [28]. However, anxiety could be a risk factor for reports of SMC [29] as 
older people may become more vigilant about their cognitive processes and aware of very 
subtle changes that are not detected by neuropsychological tests. Previous research has also 
shown that people reporting SMC were also more likely to report symptoms of anxiety and 
depression even after controlling for actual cognitive performance [30]. The findings of this 
study are in line with this research, as participants reporting SMC were more likely than those 
without SMC to experience mood problems regardless of cognitive status. 
 The MCIW category and mood problems were not significantly related, suggesting 
that it is likely that SMC mediate the relationship between MCI and mood, as the only 
difference between the MCI and MCIW categories is the presence of SMC. This idea is 
confirmed by mediation analyses, although it is probable that other factors also influence the 
relationship as the analyses suggest that SMC operate only as a partial mediator, and further 
investigation is required.  Older people without cognitive impairment may report SMC 
despite a lack of objective evidence. Such complaints may be related to mood problems, or 
could instead reflect a greater awareness of their own cognitive abilities and represent 
underlying metacognitive processes. It may be that the MCIW group includes people with 
lower levels of neuroticism who self-monitor less, and are generally less concerned about 
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health and other difficulties. If they notice cognitive difficulties, perhaps they are attributed to 
the effects of age, and not seen as noteworthy or worth reporting; others may more actively 
minimise problems as a defensive process. Others may show difficulty on objective tests, but 
not encounter difficulties in daily life. Whilst this group may be said to show a degree of 
anosognosia, a neurological basis for this is more likely in those showing more advanced 
stages of cognitive decline than apparent in this study.  
 There are several limitations to the present study. The response rate to the interviews 
from which the data were collected was approximately 46% and it could be suggested that 
potential participants with anxiety, depression or cognitive impairment may have refused to 
participate, leaving a sample that is not entirely representative, however for this analysis 
which uses relative rather than absolute differences this effect is attenuated. The measure of 
SMC is fairly crude, and may not have picked up changes in function sufficiently, rather than 
a general disposition to complain. Unlike a clinical population, the sample was not defined by 
participants identification of a difficulty and help-seeking behaviour. 
 The number of participants reporting symptoms of anxiety was small and this could 
indicate that the questions included in the interview to assess anxiety may not have been 
sensitive enough. In addition, the AGECAT algorithm [20] used to categorise the level of 
anxiety may not be effective at classifying people with less severe but more frequent anxiety 
problems and consequently may miss individuals with sub-clinical levels of anxiety. In 
addition, older people may not report anxiety, as they may trivialise the symptoms or regard 
these as a normal part of the ageing process. The present study does, however, have several 
strengths. Firstly, the data were collected from a large sample which incorporated community 
dwellers and older people living in institutions, from both urban and rural areas in Wales. In 
addition, the measures used within the interview to assess cognition such as the MMSE [31] 
and the CAMCOG [22] are very well established tools for use with older people. Lastly, the 
13 
 
use of the MCI and MCIW categories for classifying the cognitive status of the participants 
made it possible to directly compare how SMC operate in relation to mood.  
The findings from this study have several possible applications. From a theoretical 
perspective, the results raise questions regarding the inclusion of SMC as a criterion within 
the MCI definition. By insisting on the presence of SMC, many people with objective 
cognitive impairment who could benefit from timely intervention may go undetected by 
healthcare professionals. In addition, the MCI and MCIW categories may represent different 
points on the continuum between normal ageing and pathological ageing. Research suggests 
that symptoms of anxiety and depression are associated with progression from MCI to 
dementia, and the lack of relationship between mood and the MCIW category compared to 
the relationship shown with the MCI category could indicate that MCI is a step further along 
on the pathway to pathological ageing. Alternatively, the MCIW category may represent a 
separate trajectory, on which participants may progress to further cognitive decline, remain 
stable or even improve their cognitive performance. It would be informative to follow this 
sub-sample of participants over time and observe their cognitive journey. 
 Clinical applications of the findings could include the identification of symptoms of 
anxiety or depression in older people who report SMC, as the present study suggests that 
SMC may be related to mood rather than objective cognitive performance. Previous research 
found that an improvement in mood was associated with a decline in the reporting of SMC 
[28]. Coupled with research that suggests that SMC are related to a lower quality of life [32], 
this could mean that detecting and addressing mood problems could reduce SMC and in turn 
improve quality of life. Interventions to improve mood problems may in turn also help to 
reduce the chances of progression from MCI to dementia. 
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 The findings of this study highlight the requirement for more research in this area. 
The association between MCI and anxiety could be investigated with more comprehensive 
measures of anxiety, such as a scaled measurement tool, instead of using the AGECAT 
algorithm [20]. Further investigation could aim to determine the nature of anxiety in older 
people, and the worries or concerns that affect them. Understanding anxiety better in older 
people may help to develop a better understanding of how mood, cognitive function and 
SMC interact. 
This study has shown that the odds of experiencing symptoms of anxiety and 
depression are increased in participants categorised as having MCI, but the odds are not 
increased in those without cognitive impairment, or those categorised as MCIW, suggesting 
that SMC are more likely to be related to mood problems rather than objective cognitive 
impairment. The results suggest that SMC may play a mediating role in the relationship 
between cognition and mood problems. Awareness of the interplay between SMC and mood 
may help older people to obtain targeted assistance for both memory and mood problems 
which may in turn positively affect their quality of life. 
  
15 
 
Acknowledgements 
The CFAS Wales study was funded by the ESRC (RES-060-25-0060) and HEFCW as 
‘Maintaining function and well-being in later life: a longitudinal cohort study’. The grant 
holders are Professors Woods (CI). Clare (Bangor), Brayne, Matthews (Cambridge), Burholt, 
Phillips (Swansea) and Drs Windle (Bangor), Bennett and McCracken (Liverpool). We are 
grateful to the NISCHR Clinical Research Centre for their assistance in tracing participants 
and in interviewing and in collecting blood samples, and to general practices in the study 
areas for their cooperation. We would like to thank the CFAS Wales population, their 
families and carers for their participation. 
Conflicts of interest 
None declared. 
 
  
16 
 
References 
 
[1] Matthews FE, Stephan BCM, McKeith IG, Bond J, Brayne C (2008) Two year 
progression from mild cognitive impairment to dementia: To what extent do different 
definitions agree? Journal of the American Geriatrics Society 56, 1424 - 1433. 
[2] Petersen RC, Smith GE, Waring SC, Ivnik RJ, Tangalos EG, Kokmen E (1999) Mild 
cognitive impairment: Clinical characterization and outcome. Archives of Neurology 
56, 303-308. 
[3] Petersen RC, Doody R, Kurz A, Mohs RC, Morris JC, Rabins PV, Winblad B (2001) 
Current concepts in mild cognitive impairment. Archives of Neurology 58, 1985 - 
1992. 
[4] Petersen RC (2004) Mild cognitive impairment as a diagnostic entity. Journal of 
Internal Medicine 256, 183 - 194. 
[5] Portet F, Ousset PJ, Visser PJ, Frisoni GB, Nobili F, Scheltens P, Vellas B, Touchon 
J, MCI Working Group of the European Consortium on Alzheimer's Disease (EADC) 
(2006) Mild cognitive impairment (MCI) in medical practice: a critical review of the 
concept and new diagnostic procedure. Report of the MCI Working Group of the 
European Consortium on Alzheimer's Disease. Journal of Neurology, Neurosurgery 
& Psychiatry 77, 714-718. 
[6] Stephan BCM, Brayne C, McKeith IG, Bond J, Matthews FE (2008) Mild cognitive 
impairment in the older population: Who is missed and does it matter? International 
Journal of Geriatric Psychiatry 23, 863 - 871. 
[7] Lenehan ME, Klekociuk SZ, Summers MJ (2012) Absence of a relationship between 
subjective memory complaint and objective memory impairment in mild cognitive 
impairment (MCI): is it time to abandon subjective memory complaint as an MCI 
diagnostic criterion? International Psychogeriatrics 24, 1 - 10. 
[8] Roberts JL, Clare L, Woods RT (2009) Subjective memory complaints and awareness 
of memory functioning in mild cognitive impairment: A systematic review. Dementia 
and Geriatric Cognitive Disorders 28, 95 - 109. 
[9] Podewils LJ, McLay RN, Rebok GW, Lyketsos CG (2003) Relationship of self-
perceptions of memory and worry to objective measures of memory and cognition in 
the general population. Psychosomatics 44, 461-470. 
[10] Jorm AF, Christensen H, Korten AE, Henderson AS, Jacomb PA, Mackinnon A 
(1997) Do cognitive complaints either predict future cognitive decline or reflect past 
cognitive decline? A longitudinal study of an elderly community sample. 
Psychological Medicine 27, 91-98. 
[11] Iliffe S, Pealing L (2010) Subjective memory problems. BMJ 340, 703-706. 
[12] Clare L, Markova IS, Roth I, Morris RG (2011) Awareness in Alzheimer's disease 
and associated dementias: Theoretical framework and clinical implications. Aging & 
Mental Health 15, 936-944. 
[13] Schmand B, Jonker C, Geerlings MI, Lindeboom J (1997) Subjective memory 
complaints in the elderly: Depressive symptoms and future dementia. The British 
Journal of Psychiatry 171, 373-376. 
[14] Reisberg B, Shulman MB, Torossaian C, Leng L, Zhu W (2010) Outcome over seven 
years of health adults with and without subjective cognitive impairment. Alzheimer's 
& Dememtia 6, 11-24. 
[15] Jessen F, Wiese B, Bachmann C, Eifflaender-Gorfer s, Haller F, Kolsch H, Luck T, 
Mosch E, van den Bussche H, Wagner M, Wollney A, Zimmerman T, Pentzek M, 
Reidel-Heller SG, Romberg H-P, Weyerer S, Kaduszkiewicz H, Maier W, Bickel H 
(2010) Prediction of dementia by subjective memory complaints: Effects of severity 
17 
 
and temporal association with cognitive impairment. Archives of General Psychiatry 
67, 414-422. 
[16] Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K (2006) Depressive 
symptoms, vascular disease, and mild cognitive impairment: findings from the 
Cardiovascular Health Study. Archives of General Psychiatry 63, 273-279. 
[17] Yates JA, Clare L, Woods RT (2013) Mild cognitive impairment and mood: a 
systematic review. Reviews in Clinical Gerontology 23, 317-356. 
[18] Dux MC, Woodard JL, Calamari JE, Messina M, Arora S, Chik H, Pontarelli N 
(2008) The moderating role of negative affect on objective verbal memory 
performance and subjective memory complaints in healthy older adults. Journal of the 
International Neuropsychological Society 14, 327-336. 
[19] Minett TSC, Da Silva RV, Ortiz KZ, Bertolucci PHF (2008) Subjective memory 
complaints in an elderly sample: a cross-sectional study. International Journal of 
Geriatric Psychiatry 23, 49-54. 
[20] Copeland JRM, Dewey ME, Griffiths-Jones HM (1986) A computerized psychiatric 
diagnostic system and case nomenclature for elderly subjects: GMS and AGECAT. 
Psychological Medicine 16, 89-99. 
[21] Matthews FE, Stephan BCM, Bond J, McKeith I, Brayne C, on behalf of the Medical 
Research Council Cognitive Function and Ageing Study. (2007) Operationalisation of 
mild cognitive impairment: A graphical approach. . PLoS Medicine 4, e304. 
[22] Huppert FA, Brayne C, Gill C, Paykel ES, Beardsall L (1995) CAMCOG - a concise 
neuropsychological test to assist dementia diagnosis: socio-demographic determinants 
in an elderly population sample. British Journal of Clinical Psychology 34, 529-541. 
[23] Williams JG, Huppert FA, Matthews FE, Nickson J (2003) Performance and 
normative values of a concise neuropsychological test (CAMCOG) in an elderly 
population sample. International Journal of Geriatric Psychiatry 18, 631-644. 
[24] Lyketsos CG, Lopez O, Jones B, Fitzpatrick AL, Breitner J, DeKosky S (2002) 
Prevalence of neuropsychiatric symptoms in dementia and mild cognitive impairment: 
results from the cardiovascular health study. JAMA : the journal of the American 
Medical Association 288, 1475-1483. 
[25] Kruger TM, Abner EL, Mendiondo M, Schmitt FA, Smith CD, Jicha GA (2012) 
Differential reports of pain and depression differentiate mild cognitive impairment 
from cognitively intact elderly participants. Journal of Geriatric Psychiatry and 
Neurology 25, 107 - 112. 
[26] Fernandez-Martinez M, Molano A, Castro J, Zarranz JJ (2010) Prevalence of 
neuropsychiatric symptoms in mild cognitive impairment and Alzheimer's disease, 
and its relationship with cognitive impairment. Current Alzheimer research 7, 517-
526. 
[27] Van der Linde R, Stephan BCM, Matthews FE, Brayne C, Savva GM (2010) 
Behavioural and psychological symptoms in the older population without dementia – 
relationship with socio-demographics, health and cognition. Biomed Central 
Geriatrics 10. 
[28] Antikainen R, Hanninen T, Honkalampi K, Hintikka J, Koivumaa-Honkanen H, 
Tanskanen A, Viinamaki H (2001) Mood improvement reduces memory complaints 
in depressed patients. European Archives of Psychiatry and Clinical Neuroscience 
251, 6-11. 
[29] Derouesne C, Lacomblez L, Thibault S, LePoncin M (1999) Memory complaints in 
young and elderly subjects. International Journal of Geriatric Psychiatry 14, 291-
301. 
18 
 
[30] Comijs HC, Deeg DJ, Dik MG, Twisk JW, Jonker C (2002) Memory complaints; the 
association with psycho-affective and health problems and the role of personality 
characteristics. A 6-year follow-up study. Journal of Affective Disorders 72, 157-165. 
[31] Folstein MF, Folstein SE, McHugh PR (1975) ‘Mini-mental state’. A practical 
method for grading the cognitive state of patients for the clinician. Journal of 
Psychiatric Research 12, 189 - 198. 
[32] Mol MEM, van Boxtel MPJ, Willems D, Jolles J (2006) Do subjective memory 
complaints predict cognitive dysfunction over time? A six-year follow-up of the 
Maastricht Aging Study. International Journal of Geriatric Psychiatry 21, 432–441. 
 
  
19 
 
Figure 1: Flow diagram of the cognitive status algorithm 
START 
Dementia 
(AGECAT score of O3 or higher) 
Objective memory or non-memory 
cognitive impairment 
(below age adjusted norms on CAMCOG) 
YES NO 
Categorised as dementia 
and coded as 3 in the 
dataset 
NO YES 
Categorised as no cognitive 
impairment (NCI) and coded 
as 0 in the dataset 
Subjective memory complaint 
NO 
YES 
Categorised as mild cognitive 
impairment-without (MCIW) 
and coded as 2 in the dataset 
Intact general cognition 
(score ≥22 on MMSE) 
NO 
YES 
Categorised as impaired 
ADLs (ADL) and coded as 5 
in the dataset 
Intact activities of daily living (ADLs) 
Categorised other cognitive 
impairment (OCIND) and 
coded as 3 in the dataset 
NO YES 
Categorised as mild cognitive 
impairment (MCI) and coded 
as 1 in the dataset 
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A B 
  
Figure 2:The relationships between cognition and anxiety (A) and cognition and depression 
(B) are partially mediated by subjective memory complaints. Coefficients without 
parentheses indicate the direct relationship between each pair of variables; coefficients in 
parentheses indicate the (reduced) coefficient when subjective memory complaints are added 
into the regression equation relating cognition and mood 
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Table 1: Sample characteristics for participants with and without SMC 
 No SMC SMC Total (%) 
Age mean (SD) 74.34 (6.89) 74.34 (6.79)  
MMSE mean (SD) 27.55 (2.19) 27.22 (2.30) 
CAMCOG mean (SD) 85.20 (10.65) 84.83 (8.47) 
Years in FT Education mean 
(SD) 
11.73 (2.69) 11.73 (2.83) 
Female N (%) 1205 (56.8) 524 (50.1) 1729 (54.5) 
 
With anxiety N (%) 79 (3.7) 84 (8.0) 163 (5.1) 
Without anxiety N (%) 2044 (96.3) 966 (92.0) 3010 (94.9) 
 
With depression N (%) 431 (20.3) 357 (34.0) 788 (24.8) 
Without depression N (%) 1692 (79.7) 693 (66.0) 2385 (75.2) 
 
Total (%) 2123 (66.9) 1050 (33.1) 3173 (100) 
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Table 2: Sample characteristics for participants in each cognitive status group 
 NCI MCI MCIW Total (%) 
Age mean (SD) 74.31 (6.95) 73.88 (6.12) 74.87 
(6.50) 
 
MMSE mean (SD) 27.65 (2.13) 26.20 (2.43) 26.36 
(2.35) 
CAMCOG mean (SD) 86.72 (7.79) 77.81 (12.61) 76.26 
(15.67) 
Years in FT Education 
mean (SD) 
11.83 (2.80) 11.44 (2.40) 11.08 
(2.31) 
Female N (%) 1444 (54.6) 89 (44.5) 196 (59.6) 1729 (54.5) 
  
With anxiety N (%) 133 (5.03) 18 (9.0) 12 (3.6) 163 (5.1) 
  
With depression N (%) 628 (23.8) 78 (39.0) 82 (24.9) 3010 (94.9) 
 
Subjective memory 
complaint N (%) 
850 (32.1) 200 (100) 0 (0.0) 1050 (33.1) 
  
Total (%) 2644 (83.3%) 200 (6.3%) 329 
(10.4%) 
3173 (100) 
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Table 3: SMC reported for each AGECAT level of anxiety and depression 
 No SMC 
(N) 
SMC (N)   No SMC 
(N) 
SMC (N) 
Anxiety Level 0 1352 518 Depression level 0 1617 620 
Anxiety Level 1 692 448 Depression level 1 75 73 
Anxiety Level 2 32 27 Depression level 2 270 239 
Anxiety Level 3 37 37 Depression level 3 122 81 
Anxiety Level 4 10 15 Depression level 4 39 37 
Anxiety Level 5 0 5  
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Supplementary material 
Various measures of cognition were assessed using logistic regression to investigate 
the relationship with anxiety in order to select the most appropriate measure to include in the 
mediation model. The results of the logistic regressions are shown in Table S1. The 
CAMCOG median split measure of cognition is the only measure of cognition that is 
significant, and also yields a significant Sobel test statistic. Table S2 shows the sensitivity 
analyses conducted using logistic regression to investigate the relationship between cognition 
and depression. 
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Table S1: Sensitivity analyses using logistic regression to show the relationship between 
different measures of cognition and anxiety and results of the Sobel test for mediation with 
SMC as a mediating variable 
 OR CI P Sobel test P 
MCItotal 1.14 0.76-1.71 .542 2.25 .025 
CAMCOG total score 0.99 0.98-1.00 .176 -0.98 .327 
CAMCOG median split 0.65 0.47-0.89 .008 -2.29 .021 
MCItotal groups MCI and MCIW together and compares them to no cognitive impairment 
CAMCOG total score is the total score achieved by each participant on the CAMCOG 
questions asked in the interview 
CAMCOG median split is a dichotomous variable created from splitting the CAMCOG scale 
into two groups using the median of the scale 
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Table S2: Sensitivity analyses using logistic regression to show the relationship between 
different measures of cognition and depression and results of the Sobel test for mediation 
with SMC as a mediating variable 
 OR CI P Sobel test P 
MCItotal 1.39 1.13-1.71 .002 2.40 .016 
CAMCOG total score 0.98 0.98-0.99 .000 -0.99 .320 
CAMCOG median split 0.70 0.59-0.82 .000 -2.48 .013 
MCItotal groups MCI and MCIW together and compares them to no cognitive impairment 
CAMCOG total score is the total score achieved by each participant on the CAMCOG 
questions asked in the interview 
CAMCOG median split is a dichotomous variable created from splitting the CAMCOG scale 
into two groups using the median of the scale 
 
 
  
